Insider · CIK 0001247851
Ronald Hunt
Files at ITRM (Iterum Therapeutics plc), RLYB (Rallybio Corp). First filing -, latest -.
Ronald Hunt files SEC Form 4 as director at ITRM (Iterum Therapeutics plc), and also at RLYB (Rallybio Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ronald Hunt has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | RLYB Rallybio Corp | AGrant or award Option (Right to Buy)derivative | +14,305 | $3.60 | $51k | 14,305 | Feb 20, 2026 |
| May 13, 2025 | RLYB Rallybio Corp | AGrant or award Option (Right to Buy)derivative | +28,500 | $0.00 | $0 | 28,500 | May 15, 2025 |
| Jan 13, 2025 | ITRM Iterum Therapeutics plc | JOther 6.500% Exchangeable Senior Subordinated Note due 2025derivativeindirect: By New Leaf Ventures III, L.P. | - | $2,208,000.00 | - | - | Jan 23, 2025 |
| Jan 13, 2025 | ITRM Iterum Therapeutics plc | JOther 6.500% Exchangeable Senior Subordinated Note due 2025derivativeindirect: By New Leaf Biopharma Opportunities II, L.P. | - | $792,000.00 | - | - | Jan 23, 2025 |
| Jan 2, 2025 | RLYB Rallybio Corp | AGrant or award Option (Right to Buy)derivative | +73,571 | $0.70 | $51k | 73,571 | Jan 6, 2025 |
Questions about Ronald Hunt
Answered from the filings on this page, as of the latest one.
Is Ronald Hunt buying or selling?
Ronald Hunt has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ronald Hunt's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ronald Hunt has 0.
Where does Ronald Hunt file Form 4?
Ronald Hunt has filed Form 4 at ITRM (Iterum Therapeutics plc); RLYB (Rallybio Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.